What is NDC 51662-1231?

51662-1231 is the product NDC for 2% Lidocaine Hci, Lidocaine hydrochloride 20 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for 2% Lidocaine Hci?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

2% Lidocaine Hci NDC 51662-1231 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1231Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1231Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1231-1	51662123101	1 SYRINGE, PLASTIC in 1 CARTON (51662-1231-1) / 5 mL in 1 SYRINGE, PLASTICMarketed from Aug 25, 2018
51662-1231-3	51662123103	10 POUCH in 1 CASE (51662-1231-3) / 1 CARTON in 1 POUCH (51662-1231-2) / 1 SYRINGE in 1 CARTON / 5 mL in 1 SYRINGEMarketed from Mar 24, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): 2% Lidocaine Hci
Generic name (nonproprietary): 2% lidocaine hci
Active ingredients: Lidocaine hydrochloride — 20 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co. LLC, DBA Health FirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 083158
Marketing start: Aug 25, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1231_132cd630-c24a-448d-e063-6294a90a33f8SPL ID 132cd630-c24a-448d-e063-6294a90a33f8SPL set ID 74450548-62f4-b77f-e053-2991aa0ae5cfRxCUI 1012068UNII V13007Z41A
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662123101 followed by a unit qualifier and the quantity

Package 51662-1231-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 8, 2024.

Indications (excerpt from the label)

Indications and Usage Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1231

What is NDC 51662-1231?: 51662-1231 is the product NDC for 2% Lidocaine Hci, Lidocaine hydrochloride 20 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: 2% Lidocaine Hci.
What is the active ingredient?: Lidocaine hydrochloride.
Who is the labeler?: HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for 2% Lidocaine Hci?: 2 other product NDCs are listed under this name. See all 2% Lidocaine Hci NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other 2% Lidocaine Hci NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
2% Lidocaine Hci	Lidocaine hydrochloride 20 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1467	51662-1467-01
2% Lidocaine Hci	Lidocaine hydrochloride 20 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1326	51662-1326-0151662-1326-03

Other NDCs under ANDA 083158

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 083158
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride 20 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1454